CERo Therapeutics Holdings, Inc. (CERO)
NASDAQ: CERO · Real-Time Price · USD
0.9358
+0.0108 (1.17%)
Apr 29, 2025, 1:03 PM EDT - Market open

CERO Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
512694,9094,219
Market Cap Growth
-83.24%-83.24%-98.60%16.36%-
Enterprise Value
314704,909-
Last Close Price
0.936.001100.001027.03991.00
PB Ratio
-2.63-6.081574.11-446.29-550.06
Debt / Equity Ratio
-0.83-0.8367.45-0.06-
Quick Ratio
0.440.440.430.0211.20
Current Ratio
0.500.500.561.3813.88
Return on Assets (ROA)
-178.66%-178.66%-20.20%-1.63%-
Return on Capital (ROIC)
-758.66%-758.66%---
Earnings Yield
-222.80%-72.13%-10.61%-0.01%-0.01%
Buyback Yield / Dilution
----133.12%-
Updated Nov 20, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q